Product Information
- Dabrafenib related
- GW 441956X
- 2,2-Dimethylpropanethioamide
- NSC 381432
- Neopentanethioamide
- Propanethioamide, 2,2-Dimethyl-
- Propionamide, 2,2-dimethylthio-
- Thiopivalamide
Applications 2,2-Dimethylthiopropionamide is used as a reagent to synthesize Dabrafenib, an inhibitor of BRAF kinase that is used to treat BRAF V600-mutation positive carcinoma. BRAF is a gene that mediates cell growth and is activated by mutations caused by cancer. 2,2-Dimethylthiopropionamide is also used as a reagent to prepare sulfonyl-substituted 4,5-diarylthiazoles, compounds that act as cyclooxygenase-2 inhibitors (anti-inflammatory agents).
References Carter, J., et al.: Bioorg. Med. Chem. Lett., 9, 1167 (1999); Rheault, T., et al.: ACS Med. Chem. Lett., 4, 358 (2013);
Chemical properties
Technical inquiry about: TR-T796135 2,2-Dimethylthiopropionamide
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.